FRA:MRK - Merck KGaA Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €124.05 +1.30 (+1.06 %) (As of 02/23/2020 04:00 PM ET) Add Compare Today's Range€121.55Now: €124.05▼€124.0550-Day Range€107.25MA: €117.38▼€125.6052-Week Range€76.60Now: €124.05▼€115.00Volume597,321 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. Read More… Industry, Sector and Symbol Stock Exchange FRA Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolFRA:MRK Previous Symbol CUSIPN/A CIKN/A Webhttp://www.merckgroup.com/ Phone+49-6151-720Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees51,039 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive MRK News and Ratings via Email Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. MRK Rates by TradingView Merck KGaA (FRA:MRK) Frequently Asked Questions What is Merck KGaA's stock symbol? Merck KGaA trades on the FRA under the ticker symbol "MRK." What price target have analysts set for MRK? 16 Wall Street analysts have issued 12 month price objectives for Merck KGaA's stock. Their forecasts range from €94.00 to €125.00. On average, they anticipate Merck KGaA's stock price to reach €106.20 in the next twelve months. This suggests that the stock has a possible downside of 14.4%. View Analyst Price Targets for Merck KGaA. What is the consensus analysts' recommendation for Merck KGaA? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 2 sell ratings, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Merck KGaA. Has Merck KGaA been receiving favorable news coverage? Headlines about MRK stock have been trending somewhat negative recently, InfoTrie reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merck KGaA earned a news sentiment score of -1.8 on InfoTrie's scale. They also gave press coverage about the healthcare company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Merck KGaA. Who are some of Merck KGaA's key competitors? Some companies that are related to Merck KGaA include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). What other stocks do shareholders of Merck KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include Micron Technology (MU), Cisco Systems (CSCO), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), QUALCOMM (QCOM), Boeing (BA), HDFC Bank (HDB), Netflix (NFLX), AbbVie (ABBV) and Abbott Laboratories (ABT). Who are Merck KGaA's key executives? Merck KGaA's management team includes the folowing people: Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59) What is Merck KGaA's stock price today? One share of MRK stock can currently be purchased for approximately €124.05. What is Merck KGaA's official website? The official website for Merck KGaA is http://www.merckgroup.com/. How can I contact Merck KGaA? Merck KGaA's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The healthcare company can be reached via phone at +49-6151-720. MarketBeat Community Rating for Merck KGaA (FRA MRK)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 803 (Vote Outperform)Underperform Votes: 931 (Vote Underperform)Total Votes: 1,734MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: Closed-End Mutual Funds
